Chang Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Chang Liu has a total of 129 co-authors. Here are the top co-authors by number of shared publications:
Chen Gong
Department of Neurology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China
6 shared publicationsLiping Huang
Department of Neurology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China
6 shared publications- Thanh N. Nguyen
Boston Medical Center
6 shared publications - Yangmei Chen
Department of Neurology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China
6 shared publications - Jiaxing Song
The Second Affiliated Hospital of Chongqing Medical University
5 shared publications - Jiacheng Huang
Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University (Third Military Medical University), CHINA
4 shared publications
Latest Publications
- Open Access
- 7 July 2026
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 23 (7) , e1004752
Post-stroke acute heart failure in patients with large vessel occlusion undergoing endovascular treatment: A pooled analysis of individual patient data from multicenter studies with mediation analysis
Background: Cardiac complications rank among the leading contributors to poor outcomes in ischemic stroke patients along with the neurological impairment, while the risk stratification and prognostic significance of post-stroke acute heart failure (PSHF) remain poorly characterized. This study aimed to investigate the incidence, predictors, and impacts of PSHF in patients with large vessel occlusion stroke (LVO) undergoing endovascular treatment (EVT). Given that cardioembolic stroke inherently involves underlying cardiac pathology, a secondary aim was to test whether the effect of stroke severity on PSHF was modified by cardioembolic etiology and whether PSHF mediated the effect of stroke severity on functional outcome in these patients. Methods and findings: In a pooled analysis of individual patient data from four multicenter prospective studies conducted in China between January 2014 and June 2023, we included 3,415 patients with LVO who underwent EVT. The primary outcome was very poor functional outcome, defined as 90-day modified Rankin Scale (mRS) 5–6. Multivariable regression models, interaction testing, and mediation analysis were used, with adjustment for clinically relevant covariates including demographic characteristics, vascular risk factors, baseline stroke severity, imaging characteristics, and treatment-related factors. PSHF developed in 278 patients (8.14%), with its incidence reaching peak at 1 day after stroke onset. PSHF was significantly associated with a higher rate of very poor outcome (62.23% versus 31.08%, adjusted odds ratio (aOR) 3.09, 95% confidence interval (CI) [2.25, 4.24]). A significant interaction was observed between cardioembolism and the baseline National Institutes of Health Stroke Scale (NIHSS) score ( p for interaction = 0.016). Moderate-to-severe stroke significantly increased the risk of PSHF in patients with cardioembolic stroke (aOR 1.91, 95% CI [1.28, 2.87]), but not in those with non-cardioembolic stroke (aOR 0.97, 95% CI [0.81, 1.82]). Mediation analysis showed that PSHF mediated 7.70% (95% CI [2.40, 12.40]) of the effect of moderate‑to‑severe stroke on very poor outcome among cardioembolic patients. The main methodological limitations were the pooled design using studies with different protocols and the potential for residual unmeasured confounding. Conclusions: PSHF was significantly associated with very poor outcome in LVO patients undergoing EVT. Moderate-to-severe cardioembolic LVO substantially elevated the risk of PSHF, with PSHF partially mediating the adverse prognostic impact of stroke severity. Early risk assessment and monitoring for PSHF may optimize management in this high-risk population.
- 7 July 2026
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 23 (7) , e1004752
Open AccessPost-stroke acute heart failure in patients with large vessel occlusion undergoing endovascular treatment: A pooled analysis of individual patient data from multicenter studies with mediation analysis
Background: Cardiac complications rank among the leading contributors to poor outcomes in ischemic stroke patients along with the neurological impairment, while the risk stratification and prognostic significance of post-stroke acute heart failure (PSHF) remain poorly characterized. This study aimed to investigate the incidence, predictors, and impacts of PSHF in patients with large vessel occlusion stroke (LVO) undergoing endovascular treatment (EVT). Given that cardioembolic stroke inherently involves underlying cardiac pathology, a secondary aim was to test whether the effect of stroke severity on PSHF was modified by cardioembolic etiology and whether PSHF mediated the effect of stroke severity on functional outcome in these patients. Methods and findings: In a pooled analysis of individual patient data from four multicenter prospective studies conducted in China between January 2014 and June 2023, we included 3,415 patients with LVO who underwent EVT. The primary outcome was very poor functional outcome, defined as 90-day modified Rankin Scale (mRS) 5–6. Multivariable regression models, interaction testing, and mediation analysis were used, with adjustment for clinically relevant covariates including demographic characteristics, vascular risk factors, baseline stroke severity, imaging characteristics, and treatment-related factors. PSHF developed in 278 patients (8.14%), with its incidence reaching peak at 1 day after stroke onset. PSHF was significantly associated with a higher rate of very poor outcome (62.23% versus 31.08%, adjusted odds ratio (aOR) 3.09, 95% confidence interval (CI) [2.25, 4.24]). A significant interaction was observed between cardioembolism and the baseline National Institutes of Health Stroke Scale (NIHSS) score ( p for interaction = 0.016). Moderate-to-severe stroke significantly increased the risk of PSHF in patients with cardioembolic stroke (aOR 1.91, 95% CI [1.28, 2.87]), but not in those with non-cardioembolic stroke (aOR 0.97, 95% CI [0.81, 1.82]). Mediation analysis showed that PSHF mediated 7.70% (95% CI [2.40, 12.40]) of the effect of moderate‑to‑severe stroke on very poor outcome among cardioembolic patients. The main methodological limitations were the pooled design using studies with different protocols and the potential for residual unmeasured confounding. Conclusions: PSHF was significantly associated with very poor outcome in LVO patients undergoing EVT. Moderate-to-severe cardioembolic LVO substantially elevated the risk of PSHF, with PSHF partially mediating the adverse prognostic impact of stroke severity. Early risk assessment and monitoring for PSHF may optimize management in this high-risk population.
- Open Access
- 1 March 2026
- Published by Wolters Kluwer Health in Stroke: Vascular and Interventional Neurology
- Vol. 6 (2)
Endovascular Treatment in Subtypes of Posterior Large Vessel Occlusion: A Pooled Analysis From 2 Registries
BACKGROUND: Current evidence on differential outcomes of endovascular therapy for the different pathological subtypes of vertebrobasilar artery occlusion is still limited. The study aimed to compare characteristics and clinical outcomes among distinct pathological subtypes of vertebrobasilar artery occlusion undergoing endovascular therapy. METHODS: This was a posthoc pooled analysis of 1320 patients from the BASILAR (Endovascular Treatment for Acute Basilar Artery Occlusion Study; 2014–2019) and the PERSIST (Posterior Circulation Ischemic Stroke Registries; 2015–2018) registries. This analysis included adults (≥18 years) with moderate to severe vertebrobasilar artery occlusion who underwent endovascular therapy within 24 hours of their last known well. Patients were stratified by stroke mechanism: group 1 (embolism without vertebral stenosis), group 2 (tandem embolism from vertebral stenosis/occlusion), and group 3 (in situ atherosclerotic thrombosis). Baseline characteristics, procedural details, and clinical outcomes were compared across these 3 groups. The primary outcome was a favorable functional outcome, defined as a modified Rankin Scale score of 0 to 3 at 90 days. Baseline characteristics, procedural details, and clinical outcomes were compared across these 3 groups. Because the primary independent variable was categorical with no single referent category, all comparisons among the 3 groups were conducted as exploratory analyses. RESULTS: A total of 1067 patients were included (group 1, n=257 [24.08%]; group 2, n=176 [16.49%]; group 3, n=634 [59.42%]). The overall successful recanalization rate was 84.72% (904/1067), and the favorable functional outcome (90-day modified Rankin Scale score of 0–3) rate was 33.40% (275/1063). The procedure time in group 1 was significantly shorter than that in groups 2 and 3 (median time, 90 versus 135 and 110 minutes, P <0.001). There was no significant difference in the primary outcome of a favorable functional outcome among the 3 groups. After adjusting for potential confounders, group 1 exhibited a significantly higher proportion of patients achieving excellent outcomes at 90 days (modified Rankin Scale score, 0–1) compared with groups 2 and 3 (21.9% versu 17.1%, adjusted odds ratio, 0.57 [95% CI, 0.32–0.99]; 21.9% versus 16.5%, adjusted odds ratio, 0.59 [95% CI, 0.37–0.95]). No significant differences were observed in recanalization rates, favorable functional outcome, symptomatic intracranial hemorrhage, or mortality among the 3 groups. CONCLUSIONS: The outcome of endovascular therapy for vertebrobasilar artery occlusion may vary based on the stroke mechanism; patients with embolism without vertebral artery steno-occlusion may achieve excellent outcomes compared with other causes. REGISTRATION: URL: http://www.chictr.org.cn ; Unique identifier: CTR1800014759 and CTR2000033211.
- 1 March 2026
- Published by Wolters Kluwer Health in Stroke: Vascular and Interventional Neurology
- Vol. 6 (2)
Open AccessEndovascular Treatment in Subtypes of Posterior Large Vessel Occlusion: A Pooled Analysis From 2 Registries
BACKGROUND: Current evidence on differential outcomes of endovascular therapy for the different pathological subtypes of vertebrobasilar artery occlusion is still limited. The study aimed to compare characteristics and clinical outcomes among distinct pathological subtypes of vertebrobasilar artery occlusion undergoing endovascular therapy. METHODS: This was a posthoc pooled analysis of 1320 patients from the BASILAR (Endovascular Treatment for Acute Basilar Artery Occlusion Study; 2014–2019) and the PERSIST (Posterior Circulation Ischemic Stroke Registries; 2015–2018) registries. This analysis included adults (≥18 years) with moderate to severe vertebrobasilar artery occlusion who underwent endovascular therapy within 24 hours of their last known well. Patients were stratified by stroke mechanism: group 1 (embolism without vertebral stenosis), group 2 (tandem embolism from vertebral stenosis/occlusion), and group 3 (in situ atherosclerotic thrombosis). Baseline characteristics, procedural details, and clinical outcomes were compared across these 3 groups. The primary outcome was a favorable functional outcome, defined as a modified Rankin Scale score of 0 to 3 at 90 days. Baseline characteristics, procedural details, and clinical outcomes were compared across these 3 groups. Because the primary independent variable was categorical with no single referent category, all comparisons among the 3 groups were conducted as exploratory analyses. RESULTS: A total of 1067 patients were included (group 1, n=257 [24.08%]; group 2, n=176 [16.49%]; group 3, n=634 [59.42%]). The overall successful recanalization rate was 84.72% (904/1067), and the favorable functional outcome (90-day modified Rankin Scale score of 0–3) rate was 33.40% (275/1063). The procedure time in group 1 was significantly shorter than that in groups 2 and 3 (median time, 90 versus 135 and 110 minutes, P <0.001). There was no significant difference in the primary outcome of a favorable functional outcome among the 3 groups. After adjusting for potential confounders, group 1 exhibited a significantly higher proportion of patients achieving excellent outcomes at 90 days (modified Rankin Scale score, 0–1) compared with groups 2 and 3 (21.9% versu 17.1%, adjusted odds ratio, 0.57 [95% CI, 0.32–0.99]; 21.9% versus 16.5%, adjusted odds ratio, 0.59 [95% CI, 0.37–0.95]). No significant differences were observed in recanalization rates, favorable functional outcome, symptomatic intracranial hemorrhage, or mortality among the 3 groups. CONCLUSIONS: The outcome of endovascular therapy for vertebrobasilar artery occlusion may vary based on the stroke mechanism; patients with embolism without vertebral artery steno-occlusion may achieve excellent outcomes compared with other causes. REGISTRATION: URL: http://www.chictr.org.cn ; Unique identifier: CTR1800014759 and CTR2000033211.
- Open Access
- 20 February 2026
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (4) , 10031-10040
The incidence and impact of early post-stroke seizures for successful endovascular stroke treatment: an individual patient data level analysis of trials
Importance: Early post-stroke seizures (EPSS) are one of the early complications of large vessel occlusion (LVO) following endovascular treatment (EVT). However, the association between EPSS and functional outcomes remains poorly understood. Therefore, we aimed to investigate the incidence, risk factors, and clinical outcomes of EPSS in LVO patients after recanalization. Materials and methods: This study was an individual patient data level analysis of three randomized controlled trials conducted in China, including the RESCUE-BT, DEVT, and MARVEL trials. Acute ischemic stroke patients with LVO who underwent successful EVT within 24 h of symptom onset were enrolled. EPSS were defined as seizures occurring within 7 days of stroke onset, confirmed by clinical assessment with or without electroencephalography. The primary outcome was the poor outcome [90-day modified Rankin Scale (mRS) scores of 4–6]. Secondary outcomes included 90-day mortality, 90-day functional independence (mRS scores of 0–2), and early neurological function [defined as National Institutes of Health Stroke Scale (NIHSS) at 5–7 days or discharge]. Results: Of the 2862 patients screened for eligibility, 2524 patients achieved recanalization and were included, with a median (IQR) age of 69 (58–76) years; 1452 (57.5%) were men. A total of 71 (2.8%) patients developed EPSS. After adjustment of confounders, independent predictors of EPSS included higher baseline NIHSS scores and worse recanalization grade [the expanded thrombolysis in cerebral infarction (eTICI) 2b; P < 0.05]. EPSS were significantly associated with the poor outcome [adjusted odds ratio: 2.85, 95% confidence interval (CI): 1.66–4.88, P < 0.01] and worse early neurological function (β coefficient: 7.48, 95% CI: 4.80–10.17, P < 0.01). Propensity score matching and sensitivity analyses also showed consistent results. Mediation analysis suggested that the harmful effect of an unfavorable recanalization grade on the poor outcome was partly explained by its association with an increased risk of EPSS, which accounted for 1.8% (95% CI: 0.3%–8.6%) of the total effect. Conclusion: EPSS is associated with the poor outcome in acute LVO patients who achieved successful recanalization. Complete recanalization might be associated with a lower risk of EPSS, potentially contributing to better functional outcomes. These findings provide clinically relevant insights for periprocedural management in acute LVO patients.
- 20 February 2026
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (4) , 10031-10040
Open AccessThe incidence and impact of early post-stroke seizures for successful endovascular stroke treatment: an individual patient data level analysis of trials
Importance: Early post-stroke seizures (EPSS) are one of the early complications of large vessel occlusion (LVO) following endovascular treatment (EVT). However, the association between EPSS and functional outcomes remains poorly understood. Therefore, we aimed to investigate the incidence, risk factors, and clinical outcomes of EPSS in LVO patients after recanalization. Materials and methods: This study was an individual patient data level analysis of three randomized controlled trials conducted in China, including the RESCUE-BT, DEVT, and MARVEL trials. Acute ischemic stroke patients with LVO who underwent successful EVT within 24 h of symptom onset were enrolled. EPSS were defined as seizures occurring within 7 days of stroke onset, confirmed by clinical assessment with or without electroencephalography. The primary outcome was the poor outcome [90-day modified Rankin Scale (mRS) scores of 4–6]. Secondary outcomes included 90-day mortality, 90-day functional independence (mRS scores of 0–2), and early neurological function [defined as National Institutes of Health Stroke Scale (NIHSS) at 5–7 days or discharge]. Results: Of the 2862 patients screened for eligibility, 2524 patients achieved recanalization and were included, with a median (IQR) age of 69 (58–76) years; 1452 (57.5%) were men. A total of 71 (2.8%) patients developed EPSS. After adjustment of confounders, independent predictors of EPSS included higher baseline NIHSS scores and worse recanalization grade [the expanded thrombolysis in cerebral infarction (eTICI) 2b; P < 0.05]. EPSS were significantly associated with the poor outcome [adjusted odds ratio: 2.85, 95% confidence interval (CI): 1.66–4.88, P < 0.01] and worse early neurological function (β coefficient: 7.48, 95% CI: 4.80–10.17, P < 0.01). Propensity score matching and sensitivity analyses also showed consistent results. Mediation analysis suggested that the harmful effect of an unfavorable recanalization grade on the poor outcome was partly explained by its association with an increased risk of EPSS, which accounted for 1.8% (95% CI: 0.3%–8.6%) of the total effect. Conclusion: EPSS is associated with the poor outcome in acute LVO patients who achieved successful recanalization. Complete recanalization might be associated with a lower risk of EPSS, potentially contributing to better functional outcomes. These findings provide clinically relevant insights for periprocedural management in acute LVO patients.
- Open Access
- 1 May 2025
- Published by Taylor & Francis in Clinical Interventions in Aging
- Vol. ume 20, 523-535
Association Between Premorbid Frailty Status and Functional Independence in Acute Ischemic Stroke Patients Following Endovascular Treatment in the Late Window
Purpose: Although the predictive role of cerebral tissue impairment has been extensively investigated in acute ischemic stroke (AIS) patients undergoing endovascular treatment (EVT) in the late window, the impact of peripheral organs on clinical outcomes in these patients remains largely unknown. Therefore, we aimed to explore whether frailty, a reflection of the patient’s physical status based on peripheral organ health at admission, could be associated with outcomes among AIS patients treated by EVT in the late window of 6– 24 hours from stroke onset. Patients and Methods: This was a post-hoc analysis of our RESCUE-BT trial, with findings validated in an external cohort. The 5-factor modified frailty index (mFI-5), a scale of five factors that could reflect premorbid physical conditions, was applied to estimate frailty status. The primary outcome was functional independence, defined as a 90-day modified Rankin Scale (mRS) score of 0– 2. Results: There were 755 patients included in this study. After identifying the cut-off value of mFI-5 by the marginal effects approach, patients were divided into the frail group (mFI-5≥ 2) and the non-frail group (mFI-5< 2). In multivariable analysis, frailty significantly reduced the likelihood of functional independence (aOR 0.37, 95% CI 0.21– 0.65, P< 0.001). Similar results were detected in the novel cohort constructed with propensity score matching (aOR 0.44, 95% CI 0.22– 0.85, P=0.015) and in the external validation cohort (aOR 0.38, 95% CI 0.16– 0.89, P=0.028). Moreover, frailty significantly improved the predictive performance of traditional predictors with an AUC of 0.77 (P=0.036 by DeLong’s test). Conclusion: This study demonstrated that frailty according to the mFI-5 index was inversely associated with functional independence among AIS patients receiving EVT in the late window.
- 1 May 2025
- Published by Taylor & Francis in Clinical Interventions in Aging
- Vol. ume 20, 523-535
Open AccessAssociation Between Premorbid Frailty Status and Functional Independence in Acute Ischemic Stroke Patients Following Endovascular Treatment in the Late Window
Purpose: Although the predictive role of cerebral tissue impairment has been extensively investigated in acute ischemic stroke (AIS) patients undergoing endovascular treatment (EVT) in the late window, the impact of peripheral organs on clinical outcomes in these patients remains largely unknown. Therefore, we aimed to explore whether frailty, a reflection of the patient’s physical status based on peripheral organ health at admission, could be associated with outcomes among AIS patients treated by EVT in the late window of 6– 24 hours from stroke onset. Patients and Methods: This was a post-hoc analysis of our RESCUE-BT trial, with findings validated in an external cohort. The 5-factor modified frailty index (mFI-5), a scale of five factors that could reflect premorbid physical conditions, was applied to estimate frailty status. The primary outcome was functional independence, defined as a 90-day modified Rankin Scale (mRS) score of 0– 2. Results: There were 755 patients included in this study. After identifying the cut-off value of mFI-5 by the marginal effects approach, patients were divided into the frail group (mFI-5≥ 2) and the non-frail group (mFI-5< 2). In multivariable analysis, frailty significantly reduced the likelihood of functional independence (aOR 0.37, 95% CI 0.21– 0.65, P< 0.001). Similar results were detected in the novel cohort constructed with propensity score matching (aOR 0.44, 95% CI 0.22– 0.85, P=0.015) and in the external validation cohort (aOR 0.38, 95% CI 0.16– 0.89, P=0.028). Moreover, frailty significantly improved the predictive performance of traditional predictors with an AUC of 0.77 (P=0.036 by DeLong’s test). Conclusion: This study demonstrated that frailty according to the mFI-5 index was inversely associated with functional independence among AIS patients receiving EVT in the late window.
- 14 March 2025
- Published by Springer Nature in Translational Stroke Research
- Vol. 16 (5) , 1689-1697
Favorable Cerebral Collateral Cascades Improve Futile Recanalization by Reducing Ischemic Core Volume in Acute Ischemic Stroke Patients Undergoing Endovascular Treatment
Although endovascular treatment (EVT) was the first-line therapeutic strategy for acute ischemic stroke (AIS), half of the patients could not achieve functional independence. Previous studies suggested arterial collateral was an important predictor of this phenomenon. However, cerebral collateral circulation was regulated by arteries, venous, and microcirculation, and its role remained unclear. Therefore, based on the integrated cerebral collateral cascade (CCC) system, this study aimed to explore the relationship and potential mechanisms between CCC and futile recanalization. This was a multicenter retrospective study for AIS patients receiving EVT. The CCC model was used to comprehensively assess the collateral circulation, which consisted of arterial collaterals, venous outflow, and tissue-level collaterals. Imaging outcomes included ischemic core, hypoperfusion volume, and penumbra volume. The clinical outcome was futile recanalization, defined as a 90-day modified Rankin Scale (mRS) 3–6 after successful recanalization. Multivariate regression and mediation analyses were used to assess the relationship between CCC, futile recanalization, and potential mediators. Among 513 patients with successful recanalization, 50.6% (260) experienced futile recanalization. In the multivariable regression analysis, favorable CCC (aOR 0.48, 95% CI 0.31–0.75; P = 0.001) was independently associated with unfavorable outcome despite successful recanalization. Furthermore, mediation analysis revealed that favorable CCC significantly reduced the ischemic core accounting for 27.62% (95% CI 9.69–66.00%) of its beneficial effect on futile recanalization. The benefit of favorable CCC on futile recanalization may be mediated by a reduction in ischemic core volume in AIS patients undergoing EVT. Our findings deepen the understanding of futile recanalization and microcirculation.
- 14 March 2025
- Published by Springer Nature in Translational Stroke Research
- Vol. 16 (5) , 1689-1697
Favorable Cerebral Collateral Cascades Improve Futile Recanalization by Reducing Ischemic Core Volume in Acute Ischemic Stroke Patients Undergoing Endovascular Treatment
Although endovascular treatment (EVT) was the first-line therapeutic strategy for acute ischemic stroke (AIS), half of the patients could not achieve functional independence. Previous studies suggested arterial collateral was an important predictor of this phenomenon. However, cerebral collateral circulation was regulated by arteries, venous, and microcirculation, and its role remained unclear. Therefore, based on the integrated cerebral collateral cascade (CCC) system, this study aimed to explore the relationship and potential mechanisms between CCC and futile recanalization. This was a multicenter retrospective study for AIS patients receiving EVT. The CCC model was used to comprehensively assess the collateral circulation, which consisted of arterial collaterals, venous outflow, and tissue-level collaterals. Imaging outcomes included ischemic core, hypoperfusion volume, and penumbra volume. The clinical outcome was futile recanalization, defined as a 90-day modified Rankin Scale (mRS) 3–6 after successful recanalization. Multivariate regression and mediation analyses were used to assess the relationship between CCC, futile recanalization, and potential mediators. Among 513 patients with successful recanalization, 50.6% (260) experienced futile recanalization. In the multivariable regression analysis, favorable CCC (aOR 0.48, 95% CI 0.31–0.75; P = 0.001) was independently associated with unfavorable outcome despite successful recanalization. Furthermore, mediation analysis revealed that favorable CCC significantly reduced the ischemic core accounting for 27.62% (95% CI 9.69–66.00%) of its beneficial effect on futile recanalization. The benefit of favorable CCC on futile recanalization may be mediated by a reduction in ischemic core volume in AIS patients undergoing EVT. Our findings deepen the understanding of futile recanalization and microcirculation.
- Open Access
Adjunctive Intra-arterial Urokinase after Successful Endovascular Thrombectomy in Patients with Large Vessel Occlusion Stroke (POST-UK): Study protocol of a multicenter, prospective, randomized, open-label, blinded-endpoint trial
Background Intra-arterial infusion of an adjunctive thrombolytic agent after macrovascular recanalization by endovascular thrombectomy (EVT) was regarded as a promising strategy to promote outcomes of stroke patients. Given the characteristics of urokinase (UK) as an affordable, available, and widely applied medication, especially in eastern countries, this trial aims to assess the safety and efficacy of intra-arterial UK as adjunct to EVT in improving outcomes among patients with anterior large vessel occlusion stroke after excellent to complete reperfusion. Methods The Adjunctive Intra-arterial Urokinase after Successful Endovascular Thrombectomy in Patients with Large Vessel Occlusion Stroke (POST-UK) trial is a multicenter, prospective, randomized, open-label, blinded-endpoint trial conducted in China. The planned sample size is 498. Those eligible patients with anterior circulation large vessel occlusion stroke and achieving excellent to complete reperfusion by EVT are planned to be consecutively randomized in a 1:1 ratio to the experimental group (a single dose of intra-arterial urokinase) or to standard of care. Results The primary outcome is a freedom from disability (modified Rankin Scale, mRS, of 0-1) at 90±7 days. The safety outcomes are mortality within 90±7 days and symptomatic intracranial hemorrhage within 48 hours. Conclusions The POST-UK trial will provide valuable insight of efficacy and safety of intra-arterial UK in patients with large vessel occlusion stroke after achieving excellent to complete reperfusion by EVT. Trial registry number ChiCTR2200065617 (www.chictr.org.cn).
Open AccessAdjunctive Intra-arterial Urokinase after Successful Endovascular Thrombectomy in Patients with Large Vessel Occlusion Stroke (POST-UK): Study protocol of a multicenter, prospective, randomized, open-label, blinded-endpoint trial
Background Intra-arterial infusion of an adjunctive thrombolytic agent after macrovascular recanalization by endovascular thrombectomy (EVT) was regarded as a promising strategy to promote outcomes of stroke patients. Given the characteristics of urokinase (UK) as an affordable, available, and widely applied medication, especially in eastern countries, this trial aims to assess the safety and efficacy of intra-arterial UK as adjunct to EVT in improving outcomes among patients with anterior large vessel occlusion stroke after excellent to complete reperfusion. Methods The Adjunctive Intra-arterial Urokinase after Successful Endovascular Thrombectomy in Patients with Large Vessel Occlusion Stroke (POST-UK) trial is a multicenter, prospective, randomized, open-label, blinded-endpoint trial conducted in China. The planned sample size is 498. Those eligible patients with anterior circulation large vessel occlusion stroke and achieving excellent to complete reperfusion by EVT are planned to be consecutively randomized in a 1:1 ratio to the experimental group (a single dose of intra-arterial urokinase) or to standard of care. Results The primary outcome is a freedom from disability (modified Rankin Scale, mRS, of 0-1) at 90±7 days. The safety outcomes are mortality within 90±7 days and symptomatic intracranial hemorrhage within 48 hours. Conclusions The POST-UK trial will provide valuable insight of efficacy and safety of intra-arterial UK in patients with large vessel occlusion stroke after achieving excellent to complete reperfusion by EVT. Trial registry number ChiCTR2200065617 (www.chictr.org.cn).
- 14 July 2024
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 17 (8) , 823-829
Chronic mitral regurgitation predicts acute heart failure and worse outcomes after endovascular treatment for large vessel occlusion stroke
Background Valvular diseases are widely recognized as important etiologies for large vessel occlusion stroke (LVO) but their impact on outcomes among patients with LVO receiving endovascular treatment (EVT) are less well delineated. Methods This study was a post hoc exploratory analysis of the RESCUE-BT trial, DEVT trial and BASILAR prospective registry. Outcome measures included the modified Rankin Scale (mRS) score at 90 days, symptomatic intracranial hemorrhage, and post-stroke early acute heart failure (EAHF). Chronic significant mitral regurgitation (csMR) was defined as a long-existing mitral regurgitation (MR) with moderate-to-severe MR grade examined by the transthoracic echocardiography. Adjusted odds ratio (aOR) and 95% confidence interval (CI) were obtained by logistic regression models. Results Among 2011 patients in these three studies, 837 individuals receiving EVT with available information for valvular status were included in this study. In all categories of chronic valvular disorders, only csMR was related to very poor outcomes (mRS 5–6, aOR 2.76 (95% CI 1.59 to 4.78), PConclusion Our study demonstrated that csMR was a mediator of heart-brain interaction associated with poor outcomes of LVO after EVT by increasing the frequency of post-stroke EAHF. Replication of these findings in a larger cohort is warranted.
- 14 July 2024
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 17 (8) , 823-829
Chronic mitral regurgitation predicts acute heart failure and worse outcomes after endovascular treatment for large vessel occlusion stroke
Background Valvular diseases are widely recognized as important etiologies for large vessel occlusion stroke (LVO) but their impact on outcomes among patients with LVO receiving endovascular treatment (EVT) are less well delineated. Methods This study was a post hoc exploratory analysis of the RESCUE-BT trial, DEVT trial and BASILAR prospective registry. Outcome measures included the modified Rankin Scale (mRS) score at 90 days, symptomatic intracranial hemorrhage, and post-stroke early acute heart failure (EAHF). Chronic significant mitral regurgitation (csMR) was defined as a long-existing mitral regurgitation (MR) with moderate-to-severe MR grade examined by the transthoracic echocardiography. Adjusted odds ratio (aOR) and 95% confidence interval (CI) were obtained by logistic regression models. Results Among 2011 patients in these three studies, 837 individuals receiving EVT with available information for valvular status were included in this study. In all categories of chronic valvular disorders, only csMR was related to very poor outcomes (mRS 5–6, aOR 2.76 (95% CI 1.59 to 4.78), PConclusion Our study demonstrated that csMR was a mediator of heart-brain interaction associated with poor outcomes of LVO after EVT by increasing the frequency of post-stroke EAHF. Replication of these findings in a larger cohort is warranted.
- 9 May 2024
- Published by Springer Nature in European Radiology
- Vol. 34 (11) , 1-11
The impacts of venous outflow profiles on outcomes among large vessel occlusion patients receiving endovascular treatment in the late window
Objectives To investigate the association between venous outflow (VO) profiles and outcomes among acute ischemic stroke caused by anterior circulation large vessel occlusion (AIS-LVO) patients who had undergone endovascular treatment (EVT) in the late window of 6–24 h from stroke onset. Methods This was a post-hoc analysis of our preceding RESCUE-BT trial, with findings validated in an external cohort. Baseline computed tomographic angiography (CTA) was performed to assess VO using the Cortical Vein Opacification Score (COVES). The primary clinical outcome was functional independence at 90 days (modified Rankin Scale score of 0–2). The adjusted odd ratio (aOR) and confidence interval (CI) were obtained from multivariable logistic regressions. Results A total of 440 patients were included in the present study. After identifying the cutoff of COVES by marginal effects approach, enrolled patients were divided into the favorable VO group (COVES 4–6) and the poor VO (COVES 0–3) group. Multivariable logistic regression analysis showed that favorable VO (aOR 2.25; 95% CI 1.31–3.86; p = 0.003) was associated with functional independence. Similar results were detected in the external validation cohort. Among those with poor arterial collateralization, favorable VO was still an independent predictor of functional independence (aOR 2.09; 95% CI 1.06–4.10; p = 0.032). Conclusion The robust VO profile indicated by COVES 4–6 could promote the frequency of functional independence among AIS-LVO patients receiving EVT in the late window, and the prognostic value of VO was independent of the arterial collateral status. Clinical relevance statement The robust venous outflow profile was a valid predictor for functional independence among AIS-LVO patients receiving EVT in the late window (6–24 h) and the predictive role of venous outflow did not rely on the status of arterial collateral circulation.
- 9 May 2024
- Published by Springer Nature in European Radiology
- Vol. 34 (11) , 1-11
The impacts of venous outflow profiles on outcomes among large vessel occlusion patients receiving endovascular treatment in the late window
Objectives To investigate the association between venous outflow (VO) profiles and outcomes among acute ischemic stroke caused by anterior circulation large vessel occlusion (AIS-LVO) patients who had undergone endovascular treatment (EVT) in the late window of 6–24 h from stroke onset. Methods This was a post-hoc analysis of our preceding RESCUE-BT trial, with findings validated in an external cohort. Baseline computed tomographic angiography (CTA) was performed to assess VO using the Cortical Vein Opacification Score (COVES). The primary clinical outcome was functional independence at 90 days (modified Rankin Scale score of 0–2). The adjusted odd ratio (aOR) and confidence interval (CI) were obtained from multivariable logistic regressions. Results A total of 440 patients were included in the present study. After identifying the cutoff of COVES by marginal effects approach, enrolled patients were divided into the favorable VO group (COVES 4–6) and the poor VO (COVES 0–3) group. Multivariable logistic regression analysis showed that favorable VO (aOR 2.25; 95% CI 1.31–3.86; p = 0.003) was associated with functional independence. Similar results were detected in the external validation cohort. Among those with poor arterial collateralization, favorable VO was still an independent predictor of functional independence (aOR 2.09; 95% CI 1.06–4.10; p = 0.032). Conclusion The robust VO profile indicated by COVES 4–6 could promote the frequency of functional independence among AIS-LVO patients receiving EVT in the late window, and the prognostic value of VO was independent of the arterial collateral status. Clinical relevance statement The robust venous outflow profile was a valid predictor for functional independence among AIS-LVO patients receiving EVT in the late window (6–24 h) and the predictive role of venous outflow did not rely on the status of arterial collateral circulation.
- Open Access
- 8 May 2024
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 110 (8) , 4775-4784
Endovascular treatment versus standard medical treatment in patients with established large infarct: a cohort study
Background: Previous trials confirmed the benefit of endovascular treatment (EVT) in acute large core stroke, but the effect of EVT on outcomes in these patients based on noncontrast computed tomography (NCCT) in real-world clinical practice was unclear. The aim of this study was to explore the effect of EVT versus standard medical treatment (SMT) in patients with large ischemic core stroke defined as Alberta Stroke Program Early CT Score (ASPECTS) ≤5 based on NCCT alone. Materials and methods: Patients with acute large core stroke at 38 Chinese centers between November 2021 and February 2023 were reviewed from a prospectively maintained database. The primary outcome was favorable functional outcome [modified Rankin Scale score (mRS), 0–3] at 90 days. Safety outcomes included 48 h symptomatic intracerebral hemorrhage (sICH) and 90-day mortality. Results: Of 745 eligible patients recruited at 38 stroke centers between November 2021 and February 2023, 490 were treated with EVT+SMT and 255 with SMT alone. One hundred and eighty-one (36.9%) in the EVT group achieved favorable functional independence versus 48 (18.8%) treated with SMT only [adjusted risk ratio (RR), 1.86; 95% CI: 1.43–2.42, PPPPP=0.24; adjusted RD, −5.91; 95% CI: −12.91–1.09, P=0.1). Conclusion: Among patients with acute large core stroke based on NCCT in real-world, EVT is associated with better functional outcomes at 90 days despite of higher risk of sICH. Rates of procedure-related complications were relatively higher in the EVT+SMT group.
- 8 May 2024
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 110 (8) , 4775-4784
Open AccessEndovascular treatment versus standard medical treatment in patients with established large infarct: a cohort study
Background: Previous trials confirmed the benefit of endovascular treatment (EVT) in acute large core stroke, but the effect of EVT on outcomes in these patients based on noncontrast computed tomography (NCCT) in real-world clinical practice was unclear. The aim of this study was to explore the effect of EVT versus standard medical treatment (SMT) in patients with large ischemic core stroke defined as Alberta Stroke Program Early CT Score (ASPECTS) ≤5 based on NCCT alone. Materials and methods: Patients with acute large core stroke at 38 Chinese centers between November 2021 and February 2023 were reviewed from a prospectively maintained database. The primary outcome was favorable functional outcome [modified Rankin Scale score (mRS), 0–3] at 90 days. Safety outcomes included 48 h symptomatic intracerebral hemorrhage (sICH) and 90-day mortality. Results: Of 745 eligible patients recruited at 38 stroke centers between November 2021 and February 2023, 490 were treated with EVT+SMT and 255 with SMT alone. One hundred and eighty-one (36.9%) in the EVT group achieved favorable functional independence versus 48 (18.8%) treated with SMT only [adjusted risk ratio (RR), 1.86; 95% CI: 1.43–2.42, PPPPP=0.24; adjusted RD, −5.91; 95% CI: −12.91–1.09, P=0.1). Conclusion: Among patients with acute large core stroke based on NCCT in real-world, EVT is associated with better functional outcomes at 90 days despite of higher risk of sICH. Rates of procedure-related complications were relatively higher in the EVT+SMT group.